PT2968284T - Derivados alquilamina de harmina para promoção de crescimento ósseo - Google Patents

Derivados alquilamina de harmina para promoção de crescimento ósseo

Info

Publication number
PT2968284T
PT2968284T PT147700520T PT14770052T PT2968284T PT 2968284 T PT2968284 T PT 2968284T PT 147700520 T PT147700520 T PT 147700520T PT 14770052 T PT14770052 T PT 14770052T PT 2968284 T PT2968284 T PT 2968284T
Authority
PT
Portugal
Prior art keywords
amine
alkyl
bone growth
promoting bone
harmine derivatives
Prior art date
Application number
PT147700520T
Other languages
English (en)
Original Assignee
Osteoqc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteoqc Inc filed Critical Osteoqc Inc
Publication of PT2968284T publication Critical patent/PT2968284T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/02—Formic acid
    • C07C53/06—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
PT147700520T 2013-03-14 2014-03-14 Derivados alquilamina de harmina para promoção de crescimento ósseo PT2968284T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361785306P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
PT2968284T true PT2968284T (pt) 2021-06-28

Family

ID=51569593

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147700520T PT2968284T (pt) 2013-03-14 2014-03-14 Derivados alquilamina de harmina para promoção de crescimento ósseo

Country Status (16)

Country Link
US (3) US9540365B2 (pt)
EP (2) EP3915987B1 (pt)
JP (1) JP6721499B2 (pt)
CN (2) CN105120863B (pt)
CA (1) CA2899247C (pt)
DK (1) DK2968284T3 (pt)
ES (2) ES2971913T3 (pt)
HK (1) HK1218259A1 (pt)
HR (1) HRP20210931T1 (pt)
HU (1) HUE055455T2 (pt)
LT (1) LT2968284T (pt)
PL (1) PL2968284T3 (pt)
PT (1) PT2968284T (pt)
RS (1) RS62053B1 (pt)
SI (1) SI2968284T1 (pt)
WO (1) WO2014153203A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2971913T3 (es) * 2013-03-14 2024-06-10 Osteoqc Inc Derivados de un alquil-amina harmina para la promoción del crecimiento de los huesos
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US20160106687A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
CN105837569B (zh) * 2016-04-29 2017-12-26 华南农业大学 一种骆驼蓬碱噁唑啉类化合物及其制备方法和应用
CN111936490A (zh) 2017-11-20 2020-11-13 西奈山伊坎医学院 激酶抑制剂化合物和组合物及使用方法
CN111819193A (zh) 2018-01-05 2020-10-23 西奈山伊坎医学院 增加胰腺β细胞增殖的方法、治疗方法以及组合物
US11866427B2 (en) 2018-03-20 2024-01-09 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
GB201810746D0 (en) 2018-06-29 2018-08-15 Mereo Biopharma 3 Ltd Use of sclerostin antagonist
US11903949B2 (en) 2018-08-14 2024-02-20 Ossifi Therapeutics Llc Fluoro beta-carboline compounds
MX2021001752A (es) * 2018-08-14 2021-06-23 Osteoqc Inc Compuestos de pirrolo-dipiridina.
CN111773217A (zh) * 2020-06-18 2020-10-16 中国人民解放军空军军医大学 骆驼蓬碱在制备防治慢性肾脏病的药物中的应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688022A (en) * 1953-04-13 1954-08-31 Searle & Co 1-aminoalkyl-3-carbolines
US2767179A (en) * 1954-02-12 1956-10-16 Irwin Neisler And Company Quaternary ammonium salts of carboline derivatives
US2800474A (en) * 1956-03-26 1957-07-23 Searle & Co 9-(piperazinoalkyl) norharman derivatives
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5344654A (en) 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
US5324819A (en) 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US5298852A (en) 1988-12-22 1994-03-29 Robert Bosch Gmbh Arrangement for and method of controlling a three-phase-generator in a vehicle
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
EP0612348B1 (en) 1991-11-04 2003-04-23 Genetics Institute, LLC Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
TW212798B (pt) 1991-11-25 1993-09-11 Takeda Pharm Industry Co Ltd
IT1255522B (it) 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
TW270114B (pt) * 1993-10-22 1996-02-11 Hoffmann La Roche
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
DE4436190A1 (de) 1994-10-10 1996-04-11 Gerhard Prof Dr Bringmann Halogenierte ß-Carbolin-Derivate, Verfahren zu ihrer Herstellung und Verwendung dieser Substanzen zur Hemmung der Atmungskette
DE19613549A1 (de) 1996-04-04 1997-10-09 Bayer Ag Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
US5939039A (en) 1997-01-16 1999-08-17 Orthovita, Inc. Methods for production of calcium phosphate
ATE239514T1 (de) 1997-02-07 2003-05-15 Stryker Corp Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
WO2000002878A1 (en) 1998-07-11 2000-01-20 University Of Bristol Compounds having activity at imidazoline receptors
US6025538A (en) 1998-11-20 2000-02-15 Musculoskeletal Transplant Foundation Compound bone structure fabricated from allograft tissue
AU3395000A (en) 1999-03-10 2000-09-28 Merck & Co., Inc. 6-azaindole compounds as antagonists of gonadotropin releasing hormone
US20070060606A1 (en) 1999-10-07 2007-03-15 Robertson Harold A Compounds and methods for modulating phosphodiesterase 10A
AU3741801A (en) 2000-03-15 2001-09-24 Aventis Pharma Gmbh Substituted beta-carbolines with ikb-kinase inhibiting activity
EP1209158A1 (en) 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substituted beta-carbolines
EP1134221A1 (en) 2000-03-15 2001-09-19 Aventis Pharma Deutschland GmbH Substituted beta-carbolines as lkB kinase inhibitors
US20030082233A1 (en) 2000-12-01 2003-05-01 Lyons Karen M. Method and composition for modulating bone growth
WO2002067978A1 (en) 2001-02-23 2002-09-06 Wyeth Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
CN100515504C (zh) 2001-10-12 2009-07-22 美国英佛曼公司 涂层,涂布体及其制造方法
JP3646167B2 (ja) 2002-02-19 2005-05-11 独立行政法人産業技術総合研究所 フォスフォフォリンを含む複合生体材料
US7176322B2 (en) 2002-05-23 2007-02-13 Amgen Inc. Calcium receptor modulating agents
US20050085554A1 (en) 2003-06-26 2005-04-21 Hamann Mark T. Methods of treating disease through the administration of a manzamine analog or derivative
FI20031120A0 (fi) 2003-07-31 2003-07-31 Bci Bioabsorbable Concepts Ltd Monifunktionaalinen implanttilaite
US7189263B2 (en) 2004-02-03 2007-03-13 Vita Special Purpose Corporation Biocompatible bone graft material
US8071574B2 (en) 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
EP1923929B1 (en) 2005-09-08 2014-12-03 Idemitsu Kosan Co., Ltd. Organic electroluminescence device
EP1962907A2 (en) 2005-12-21 2008-09-03 Wyeth a Corporation of the State of Delaware Protein formulations with reduced viscosity and uses thereof
JP5080284B2 (ja) 2006-02-10 2012-11-21 株式会社エリナ 骨疾患の予防及び／又は治療用医薬組成物、その組成物を含有する機能性食品、健康食品及び医薬製剤、並びに歯根−歯周組織形成促進剤
EP1989203A2 (en) * 2006-02-16 2008-11-12 Millennium Pharmaceuticals, Inc. Alpha carbolines and uses thereof
WO2009029625A1 (en) * 2007-08-27 2009-03-05 Kalypsys, Inc. 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors
CA2932121A1 (en) 2007-11-30 2009-06-11 Newlink Genetics Corporation Ido inhibitors
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
DK2262808T3 (da) * 2008-03-28 2013-11-04 Altiris Therapeutics Chemokinreceptormodulatorer
EP2151441A1 (en) 2008-08-06 2010-02-10 Julius-Maximilians-Universität Würzburg Beta-carbolin-derivates as substrates for an enzyme
US20100063085A1 (en) 2008-09-11 2010-03-11 University Court Of The University Of Dundee Method of treating learning impairment in down's syndrome subjects
US20100074939A1 (en) * 2008-09-25 2010-03-25 Osteogenex Inc. Harmine compounds for promoting bone growth
WO2010080756A2 (en) 2009-01-06 2010-07-15 Osteogenex, Inc. Harmine derivatives for reducing body weight
US8927570B2 (en) 2009-04-24 2015-01-06 John K. Buolamwini 1-naphthyl-or 1-dihydroacenaphthenyl-pyrido[B]indoles and uses thereof in treating cancers
US8329723B2 (en) 2009-04-24 2012-12-11 John K Buolamwini 1-aryl- or 1-heteroaryl-pyrido[B]indoles and uses thereof in treating cancers
AU2010338669A1 (en) 2009-12-28 2012-06-21 Audiocure Pharma Gmbh Beta-carbolines for use in the treatment of hearing loss and vertigo
US20130231360A1 (en) * 2010-04-22 2013-09-05 The Brigham And Women S Hospital, Inc. Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases
US9168247B2 (en) 2010-06-25 2015-10-27 Facultes Universitaires Notre Dame De La Paix Beta carboline derivatives useful in the treatment of proliferative disorders
WO2012024433A2 (en) 2010-08-17 2012-02-23 Translational Genomics Research Institute Compounds that inhibit tau phosphorylation
CN102796124B (zh) 2011-05-26 2017-06-06 新疆华世丹药物研究有限责任公司 双β‑咔啉碱类化合物、其制法和其药物组合物与用途
US20130315965A1 (en) 2012-05-15 2013-11-28 OssiFi, Inc. Harmine derivatives for promoting bone growth
ES2971913T3 (es) * 2013-03-14 2024-06-10 Osteoqc Inc Derivados de un alquil-amina harmina para la promoción del crecimiento de los huesos
WO2018024643A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives

Also Published As

Publication number Publication date
EP3915987A1 (en) 2021-12-01
US11267814B2 (en) 2022-03-08
PL2968284T3 (pl) 2021-09-27
CN105120863A (zh) 2015-12-02
US20200172538A1 (en) 2020-06-04
EP2968284A4 (en) 2016-08-17
LT2968284T (lt) 2021-07-12
CN113416187A (zh) 2021-09-21
HK1218259A1 (zh) 2017-02-10
CN105120863B (zh) 2021-06-04
EP3915987B1 (en) 2023-12-13
DK2968284T3 (da) 2021-06-14
JP2016519082A (ja) 2016-06-30
US9540365B2 (en) 2017-01-10
EP2968284B1 (en) 2021-04-21
ES2875874T3 (es) 2021-11-11
JP6721499B2 (ja) 2020-07-15
WO2014153203A2 (en) 2014-09-25
HRP20210931T1 (hr) 2021-09-03
RS62053B1 (sr) 2021-07-30
CA2899247C (en) 2023-04-04
ES2971913T3 (es) 2024-06-10
US10501457B2 (en) 2019-12-10
SI2968284T1 (sl) 2021-08-31
HUE055455T2 (hu) 2021-11-29
EP2968284A2 (en) 2016-01-20
CA2899247A1 (en) 2014-09-25
US20140288068A1 (en) 2014-09-25
WO2014153203A3 (en) 2014-11-13
EP3915987C0 (en) 2023-12-13
US20170298059A1 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
HK1218259A1 (zh) 促進骨生長的烷基胺駱駝蓬碱衍生物
IL243599A0 (en) surgical implant
IL240398A0 (en) surgical implant
IL240349B (en) surgical implant
IL264738B (en) graft
IL240534A0 (en) surgical implant
EP2950303A4 (en) PEDAL HOLDER FOR ELECTROPHONE INSTRUMENTS
EP2961764A4 (en) PROCESS FOR THE PRODUCTION OF TUBULYSINES
HK1203857A1 (en) Method for preparing biological tissue
GB201322237D0 (en) Surgical reamer
SG11201505498YA (en) Method for preparing polybutene
GB201320618D0 (en) Apparatus for robotic surgery
PL3062718T3 (pl) Implant do osteotomii
SG11201508193TA (en) Method for generating extended sequence reads
EP3533412C0 (en) ENHANCED DISINTEGRABLE BONE IMPLANTS
KR101391404B9 (ko) 골신장기
GB201313526D0 (en) Orthopaedic Apparatus
EP2870929C0 (en) Surgical attachment device
HK1212353A1 (en) Method for preparing coumestrol or coumestrin
ZA201504764B (en) Method for measuring bone loss rate
IL242897A0 (en) A process for the preparation of pyridylpyrazole compounds and their derivatives from pyridylhydrazine
GB201307817D0 (en) Bone Growth Scaffold
EP2993166A4 (en) PROCESS FOR PURIFYING DIMETHYL SULFOXIDE
GB201302143D0 (en) Bone reponator
IL239993A0 (en) Process for preparing 5-fluoro-1-methyl-3-difluoromethyl-h1-pyrazole-4-carbaldehyde